UBE2N and neoplasm: Furthermore, UBC13 low-expression was significantly correlated with a high-grade tumor (P = 0.038), larger volume of ascitic fluid (P = 0.006), suboptimal primary surgery (P = 0.023), and chemoresistance (P = 0.001) (Table 1).